抗抑郁药:好药还是好营销?

关于青少年自杀的隐藏数据丑闻揭示了我们药物审批系统的一个黑暗角落

加入我们的科学爱好者社区!

00

(Further Reading)

  • Suppression of Mosholder’s findings and testimony is documented by Anna Wilde Mathews’s article “In Debate over Antidepressants, FDA Weighed Risk of False Alarm Doubting Data on Suicide and Kids” in Wall Street Journal; May 25, 2004. Viewable at www.ahrp.org/infomail/04/05/25.html

  • Drug Company Experts Advised Staff to Withhold Data about SSRI Use in Children. Wayne Kondro in Canadian Medical Association Journal, Vol. 170; No. 5; March 2, 2004. Available online at www.cmaj.ca/cgi/content/full/170/5/783

SA Mind Vol 14 Issue 5This article was originally published with the title “Perspectives: Antidepressants: Good Drugs or Good Marketing” in SA Mind Vol. 14 No. 5 (), p. 10
doi:10.1038/scientificamericanmind1204-10
© . All rights reserved.